Elon Musk, pharma, and the future of Twitter
pharmaphorum
NOVEMBER 22, 2022
Ben Hargreaves explores how the current uncertainty surrounding Twitter could dissuade both from using the platform. Roberts stated, “I think there’s enough to suggest that more pharmaceutical organisations, as well as organisations from other sectors, will follow suit and pause with Twitter.”. How to react.
Let's personalize your content